Digital Integration: The key to scalable decentralised trials Successful DCTs depend less on the technology deployed and more on how effectively those capabilities are integrated and executed.
Patients From access to advocacy: Turning patients into brand champio... Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Market Access In DTC's watershed moment, trust and partnership are key More and more pharma companies are turning to direct-to-patient access models. But the consensus at Reuters Pharma USA is that they can't do it alone.
Patients DTC pharma is America’s newest care pathway. TrumpRx has exp... Today’s DTP platforms vary widely in standards, screening protocols, clinical follow-up, data use, and integration with a patient’s broader care team
Oncology ASCO 2026: Can a blood test spot cancer early? with Dr Peter... Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
